首页 › 基金 › Patient Square Capital LP › PCVX

Patient Square Capital LP 对 PCVX 的持仓历史

VAXCYTE INC · 医疗保健

Patient Square Capital LP 在 Q3 2026 的 13F 申报中披露持有 PCVX(VAXCYTE INC)166,000 股,市值约 US$9.4M,约占其申报组合的 1.51%,在其申报持仓中市值排名第 18 位。 Patient Square Capital LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)166.00K 股
申报持仓市值$9.45M
组合权重1.51%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Patient Square Capital LP 对 PCVX 的持仓演变

Patient Square Capital LP 于 Q3 2026 首次披露 PCVX 持仓:166,000 股(约 US$9.4M)。

逐季持仓明细

季度股数金额变化
Q3 2026 166.00K $9.45M 新进

关于 PCVX 与 13F 数据

PCVX(VAXCYTE INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 PCVX,申报仓位最大的包括:Jupiter Topco LLC (US$1.04B), 骏利亨德森集团 (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PCVX 的基金

查看 PCVX 的全部基金持有人 →

常见问题

How long has Patient Square Capital LP held PCVX?

Patient Square Capital LP has disclosed PCVX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Patient Square Capital LP's current position in PCVX?

As of Q3 2026, Patient Square Capital LP holds 166.00K shares of PCVX (VAXCYTE INC), valued at $9.45M, representing 1.51% of its reported portfolio and ranking #18.

Has Patient Square Capital LP been buying or selling PCVX?

In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in PCVX.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, 骏利亨德森集团, T. Rowe Price Investment Management, Inc., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.